Nicoletta Ladisa

Therapeutic Immunization with HIV-1 Tat Reduces Immune Activation and Loss of Regulatory T-Cells and Improves Immune Function in Subjects on HAART

Barbara Ensoli, Stefania Bellino, Antonella Tripiciano et al. · PLoS ONE · 2010 · 95 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15

Evaluation of Liver Fibrosis: Concordance Analysis between Noninvasive Scores (APRI and FIB-4) Evolution and Predictors in a Cohort of HIV-Infected Patients without Hepatitis C and B Infection

Monia Mendeni, Emanuele Focà, D Gotti et al. · Clinical Infectious Diseases · 2011 · 77 citations · Full text

Medicine, Infectious Diseases, Clinical Epidemiology +16

Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy

Carlo Torti, Mattia Prosperi, Davide Motta et al. · Clinical Microbiology and Infection · 2011 · 69 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Real Versus Virtual Phenotype to Guide Treatment in Heavily Pretreated Patients: 48-Week Follow-Up of the Genotipo-Fenotipo di Resistenza (GenPheRex) Trial

Francesco Mazzotta, Sergio Lo Caputo, Carlo Torti et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2003 · 63 citations

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Survival in HIV-Infected Patients after a Cancer Diagnosis in the cART Era: Results of an Italian Multicenter Study

D Gotti, Elena Raffetti, Laura Albini et al. · PLoS ONE · 2014 · 61 citations · Full text

Public Health, Biostatistics, Clinical Sciences +17